# Recombinant H7 Hemagglutinin Influenza Vaccine Trial

> **NCT03038776** · PHASE1 · COMPLETED · sponsor: **Vaxine Pty Ltd** · enrollment: 150 (estimated)

## Conditions studied

- Influenza, Avian

## Interventions

- **BIOLOGICAL:** Recombinant influenza hemagglutinin

## Key facts

- **NCT ID:** NCT03038776
- **Lead sponsor:** Vaxine Pty Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2017-11
- **Final completion:** 2019-05
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03038776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03038776, "Recombinant H7 Hemagglutinin Influenza Vaccine Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03038776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*